Latest Advanced Prostate Cancer News2017-10-19T10:43:14-04:00

A Step Towards Understanding How To Get A Fair Value For The Dollars Spent For Advanced Prostate Cancer Treatment

In the treatment of prostate cancer the first very expensive drug we had that was FDA approved was Provenge, with an initial cost of $93,000 for a one-month’s treatment protocol. Today, the cost is in [...]

View The Congressional Record And Read Senator McCain’s Attempt To Cut The DOD CDMRP

Yesterday, the United States Senate debated the Defense Spending Bill. As expected Senator McCain’s amendment came up for debate. I have attached a link to the Congressional Record, which includes both Senator McCain’s remarks against [...]

By |June 18th, 2015|Categories: Advanced Prostate Cancer, Advocacy, DOD, Politics of Cancer, Uncategorized|Tags: |0 Comments

What Does the Prostate Cancer CDMRP Do And Why Is It So Important?

The problems created by Senator McCain continue to be ever present.  Our friend, Senator Durbin has asked that we provide his office with additional background about the military nature of the research performed by the [...]

Long-Term Survival Possible in Prostate Cancer With Bone Metastases

Men who develop bone metastases have often been viewed as having developed a significant negative change that prognosticates a negative impact on both their quality of life and on their survival. Contradicting this commonly held [...]

Enzalutamide (Xtandi) Improves The Quality of Life As Well As Extending Life In Men With Castrate Resistant Prostate Cancer

In clinical trials Enzalutamide (Xtandi) significantly increased the overall survival and radiographic progression-free survival of men when compared with placebo. The trial, called PREVAIL evaluated men who were asymptomatic and minimally symptomatic, chemotherapy-naive with metastatic [...]

Go to Top